[adrotate group="2"]
FDA CHAOS: A Shocking Retreat on Office Orders – Workers BACK to Remote!
BAFFLING TURN OF EVENTS: FDA REVERSES OFFICE MANDATE!
In a jaw-dropping about-face, the Food and Drug Administration (FDA) is scrambling to restore order as fear grips the agency! Just weeks after demanding employees return to the office, they’re now allowing some of their KEY staff to work from HOME! Why? Because their precious operation is hanging by a thread with recent layoffs and resignations throwing crucial functions, like approving new medicines, into turmoil!
INSIDE SCOOP: An Emergency Telework Policy!
An exclusive internal email reveals that FDA’s leadership has decided to let drug reviewers and supervisors work remotely at least TWO DAYS A WEEK! FDA staffers, speaking under the cloak of anonymity, confirmed this shocking shift, adding that similar incentives were communicated across vaccine and medical device reviewers.
TRUMP’S DISASTROUS FDA OVERHAUL: A HAUNTING NIGHTMARE!
This isn’t just a corporate shakeup; it’s an utter disaster! The Trump administration’s insane strategy tearing the federal health workforce apart has resulted in mass firings, frantic rehiring campaigns, and a jaw-dropping layoff of 3,400 (that’s RIGHT – over 15%) of the agency’s team just last week!
Full offices dedicated to FDA’s policy and regulations were obliterated along with most of the communication staff! Those responsible for tobacco, brand new drugs, vaccines – they’ve been shown the door too! Witnesses describe lower-level employees “pouring” out of the agency like it’s sinking!
FORMER FDA COMMISSIONER SLAMS CUTS AS CHAOTIC!
David Kessler, once the top dog at the FDA, dropped a bomb during Congress this week, calling the cuts “devastating, haphazard, thoughtless, and chaotic.”
HHS SECRETARY’S AJUSTED CUTS: A NICE CHANGE? NOT SO FAST!
Health Secretary Robert F. Kennedy Jr. made waves when he announced a shocking plan to ax TEN THOUSAND positions across the federal health sector, but boldly claimed that FDA medical reviewers and safety inspectors would be unscathed. We know what you’re thinking—what’s the REAL story behind HHS?
THREAT OF CRIPPLING BUDGET CRISIS LOOMS!
Here’s the kicker: with mass cuts and resignations, a dangerous NEW threat has emerged! The FDA could plunge into a budget abyss that could CRIPPLE its operations! Nearly HALF of the FDA’s $7 billion budget is funded by FAT fees from drug and device companies! If their federal funding dips below a crucial level, these companies could STOP paying and even demand their money BACK!
ARE USER-FEE AGREEMENTS IN JEOPARDY?
Negotiations between FDA and industry groups are slated for this year to renew vital user-fee agreements, funding that is a lifeline to the operation. Michael Gaba, an attorney with insight into FDA matters, warns, “Neither the agency nor industry can afford to let user fees expire!”
NEW FDA COMMISSIONER ON A MISSION!
This whirlwind of chaos has led to one powerful question: Is new FDA Commissioner Marty Makary trying to steer this sinking ship back to safety? Confirmed recently, he’s already signaled the return to telework for some employees. As Makary made his debut appearance at FDA headquarters just after the devastating layoffs, insiders note he’s on a hunt to rebuild his fragmented teams.
“Dr. Makary MUST kick-start productivity lost in recent weeks of sheer job uncertainty!” says former HHS official Steven Grossman. “Turning commuting time back into WORK time is a step to recovery!”
As the FDA navigates this wild storm, one thing’s clear: the battle for the future of our health oversight agency is far from over! Stay tuned, folks!
photo credit: fortune.com
[adrotate group="2"]
